MindMaze Therapeutics Holding SA RLFTF Stock
MindMaze Therapeutics Holding SA Price Chart
MindMaze Therapeutics Holding SA RLFTF Financial and Trading Overview
| MindMaze Therapeutics Holding SA stock price | 0.28 USD |
| Previous Close | 0.29 USD |
| Open | 0.33 USD |
| Bid | 0.25 USD x 250000 |
| Ask | 0.32 USD x 250000 |
| Day's Range | 0.33 - 0.33 USD |
| 52 Week Range | 0.27 - 4.88 USD |
| Volume | 2.5K USD |
| Avg. Volume | 3.89K USD |
| Market Cap | 3.59M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RLFTF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.5900965 |
| Price/Book (mrq) | 0.91348106 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
MindMaze Therapeutics Holding SA Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -89.74% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 4.88 USD |
| 52 Week Low | 0.27 USD |
| 50-Day Moving Average | 0.44 USD |
| 200-Day Moving Average | 1.96 USD |
RLFTF Share Statistics
| Avg. Volume (3 month) | 3.89K USD |
| Avg. Daily Volume (10-Days) | 4.71K USD |
| Shares Outstanding | 12.59M |
| Float | 37.2M |
| Short Ratio | N/A |
| % Held by Insiders | 58.29% |
| % Held by Institutions | 26.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:400 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1637.84% |
| Gross Margin | 92.05% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.46% |
| Return on Equity (ttm) | -51.55% |
Income Statement
| Revenue (ttm) | 642K USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 591K USD |
| EBITDA | -9143000 USD |
| Net Income Avi to Common (ttm) | -9906000 USD |
| Diluted EPS (ttm) | -1.7 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.203 |
| Book Value Per Share (mrq) | 0.31089863 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7208000 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of MindMaze Therapeutics Holding SA
| Country | United States |
| State | N/A |
| City | Geneva |
| Address | Avenue de Sécheron 15 |
| ZIP | 1202 |
| Phone | 41 21 552 08 01 |
| Website | https://mindmazetherapeutics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 10 |
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Q&A For MindMaze Therapeutics Holding SA Stock
What is a current RLFTF stock price?
MindMaze Therapeutics Holding SA RLFTF stock price today per share is 0.28 USD.
How to purchase MindMaze Therapeutics Holding SA stock?
You can buy RLFTF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MindMaze Therapeutics Holding SA?
The stock symbol or ticker of MindMaze Therapeutics Holding SA is RLFTF.
How many shares does MindMaze Therapeutics Holding SA have in circulation?
The max supply of MindMaze Therapeutics Holding SA shares is 12.64M.
What is MindMaze Therapeutics Holding SA Price to Earnings Ratio (PE Ratio)?
MindMaze Therapeutics Holding SA PE Ratio is now.
What was MindMaze Therapeutics Holding SA earnings per share over the trailing 12 months (TTM)?
MindMaze Therapeutics Holding SA EPS is -1.7 USD over the trailing 12 months.